삼성서울병원

Ko En

핵의학과 이현종 교수

진료분야
종양핵의학, 심장핵의학, 일반핵의학
진료일정 05 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
오전
오후
진료일정 06 月
날짜
01
02
03
04
05
06
07
08
09
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
오전
오후

학력

학력
2021.08 서울대학교 융합과학기술대학원 분자의학 및 바이오제약학과 박사
2013.02 서울대학교 의과대학 의학과 학사

경력

경력
2025.03 ~현재 성균관대학교 의과대학 삼성서울병원 핵의학과 조교수
2024.03 ~ 2025.02 삼성서울병원 핵의학과 전임대우조교수
2023.03 ~ 2024.02 삼성서울병원 핵의학과 임상조교수
2021.05 ~ 2023.02 삼성서울병원 핵의학과 임상강사
2019.04 ~ 2021.04 경기도 포천시 신북보건지소 공중보건의
2018.04 ~ 2019.04 전라남도 신안군 가거도보건지소 공중보건의
2018.03 핵의학과 전문의 취득
2014.03 ~ 2018.02 서울대학교병원 핵의학과 레지던트과정 수료
2016.12 방사선취급 감독자면허 취득
2016.09 방사성동위원소취급자 특수면허 취득
2013.03 ~ 2014.02 서울대학교병원 인턴과정 수료

학회활동

학회활동
2018.03 ~ 현재 대한핵의학회 정회원

수상이력

수상이력
2023.11 대한핵의학회추계학술대회 프론티어 의학자상
2015.11 대한핵의학회 추계학술대회 구연상
  • SCI REP-UK 2025 10.1038/s41598-024-83787-5 Prognostic value of [18F]FDG PET/CT in patients with idiopathic pulmonary fibrosis Whi, W; Lee, H; Cho, YS; Lee, H; Yoo, H; Chung, MP; Choi, JY
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-83109-9 Prognostic value of pseudotime from texture parameters of FDG PET/CT in locally advanced rectal cancer with neoadjuvant concurrent chemoradiotherapy Lee, H; Hyun, SH; Cho, YB; Kim, HC; Park, HC; Park, YS; Choi, JY
    View PubMed
  • SCI REP-UK 2024 10.1038/s41598-024-68987-3 PET imaging of colon cancer CD73 expression using cysteine site-specific 89Zr-labeled anti-CD73 antibody Jung, KH; Kim, M; Jung, HJ; Koo, HJ; Kim, JL; Lee, HYJ; Lee, KH
    View PubMed
  • MOL PHARMACEUT 2024 10.1021/acs.molpharmaceut.3c01024 Imaging Very Late Antigen-4 on MOLT4 Leukemia Tumors with Cysteine Site-Specific 89Zr-Labeled Natalizumab Immuno-Positron Emission Tomography Kim, M; Jung, KH; Kim, JL; Koo, HJ; Jung, HJ; Lee, H; Lee, KH
    View PubMed
  • FRONT ONCOL 2023 10.3389/fonc.2023.1283582 Metabolic bulk volume from FDG PET as an independent predictor of progression-free survival in follicular lymphoma So, H; Lee, H; Hyun, SH; Cho, YS; Moon, SH; Choi, JY; Lee, KH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-45296-9 Comparative analysis of batch correction methods for FDG PET/CT using metabolic radiogenomic data of lung cancer patients Lee, H; Seo, S; Won, S; Park, WY; Choi, JY; Lee, KH; Lee, SH; Moon, SH
    View PubMed
  • CANCER IMAGING 2023 10.1186/s40644-023-00625-z Semi-quantitative FDG parameters predict survival in multiple myeloma patients without autologous stem cell transplantation Lee, H; Hyun, SH; Cho, YS; Moon, SH; Choi, JY; Kim, K; Lee, KH
    View PubMed
  • CANCERS 2023 10.3390/cancers15174380 Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery Lee, H; Choi, YL; Kim, HK; Choi, YS; Kim, H; Ahn, MJ; Pyo, HR; Choi, JY
    View PubMed
  • CANCERS 2023 10.3390/cancers15153841 A Machine Learning Approach Using FDG PET-Based Radiomics for Prediction of Tumor Mutational Burden and Prognosis in Stage IV Colorectal Cancer Lee, H; Moon, SH; Hong, JY; Lee, J; Hyun, SH
    View PubMed
  • SCI REP-UK 2023 10.1038/s41598-023-34653-3 Cluster analysis of autoencoder-extracted FDG PET/CT features identifies multiple myeloma patients with poor prognosis Lee, H; Hyun, SH; Cho, YS; Moon, SH; Choi, JY; Kim, K; Lee, KH
    View PubMed
  • J BREAST CANCER 2023 10.4048/jbc.2023.26.e17 Prognostic Impact of Elevation of Cancer Antigen 15-3 (CA15-3) in Patients With Early Breast Cancer With Normal Serum CA15-3 Level Ryu, JM; Kang, DB; Cho, JH; Lee, JE; Kim, SW; Nam, SJ; Lee, SK; Kim, YJ; Im, YH; Ahn, JS; Park, YH; Kim, JY; Lee, HYJ; Kang, MR; Yu, JH
    View PubMed
  • FRONT ONCOL 2022 10.3389/fonc.2022.828505 Investigating the Clinico-Molecular and Immunological Evolution of Lung Adenocarcinoma Using Pseudotime Analysis Lee, H; Choi, H
    View PubMed
  • SCI REP-UK 2021 10.1038/s41598-021-93743-2 Discovery of potential imaging and therapeutic targets for severe inflammation in COVID-19 patients Lee, H; Park, J; Im, HJ; Na, KJ; Choi, H
    View PubMed

해당하는 결과가 없습니다.